Cryptogenic fîbrosing alveolitis: A clinicopathological entity

Current Diagnostic Pathology

Volumn 3, Issue 1, 1996, Pages 27-34

  Wallace, W A H ^a   Lamb, D ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0003142873     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-6053(05)80030-4     Document Type: Article

References (75)

1. Liebow A A, Carrington C B. Alveolar Diseases. The Interstitial Pneumonias. In: Simon M, Potchen E J, Lemay M, eds. Frontiers of Pulmonary Radiology. Grune and Stratton, New York: 1967, 102-141.
2. Scadding J G. Fibrosing alveolitis. Brit Med J 1964; 2: 686.
3. Hamman L, Rich A R. Fulminating diffuse interstitial fibrosis of the lungs. Trans Am Clin Climatol Assoc 1935; 51: 154-163.
4. Hamman L, Rich A R. Acute diffuse interstitial fibrosis of the lungs. Bull Johns Hopkins Hosp 1944; 74: 177-212.
5. Rindfleisch E. Zbl Allg Path Anat 1897; 8: 864.
6. Sandoz E. Über zwei Falle von 'Fötaler Bronchektasie'. Beitr Pathol Anat 1907; 41:495-596.
7. Potter B P, Gerber I E. Acute diffuse interstitial fibrosis of the lungs. Report of a case. Arch Int Med 1948; 82: 113-124.
8. Stursa M. Interstitial pneumonia with chronic course. Cas Lek Ces 1949; 88:464-466.
9. Beams A J, Harmos O. Diffuse progressive interstitial fibrosis of the lung. Am J Med 1949; 7:425-430.
10. Goldin A, Tullis I F. Diffuse interstitial fibrosis of lungs. Mil Surg 1949; 105: 130-137.
11. Grant I W B, Hillis B R, Davidson J. Diffuse interstitial fibrosis of the lungs (Hamman-Rich Syndrome). Am Rev Tuber Pulm Dis 1956:74:485-510.
12. Livingstone J L, Lewis J G, Reid L, Jefferson K E. Diffuse interstitial fibrosis: a clinical, radiological and pathological study based on 45 patients. Q J Med 1964; 33: 71-103.
13. Office of Population Censuses and Surveys. Mortality Statistics Cause 1990. HMSO, London: 1991.
14. Spencer H. Pneumonias due to rickettsiae, chlamydia, viruses and mycoplasma. In: Pathology of the Lung. Pergammon Press: Oxford: 1985: 222-259.
15. Weill H, Turner-Warwick M. Eds. Lung Biology in Health and Disease. Chapters in Volume 18, Occupational Lung Diseases. Marcel Dekker: New York, 1981.
16. Vale J A, Meredith T J. Paraquot poisoning. In: Vale J A, Meredith T J, eds. Poisoning Diagnosis and Treatment. Update Books: London, 1991: 135-141.
17. Hasleton P S. Adult respiratory distress syndrome - a review. Histopathology 1983; 7: 307-332.
18. Bartels H, Reale E. Early and late ultrastructural changes in the lungs of patients suffering from severe polytrauma. In: Sturm J A, ed. Adult Respiratory Distress Syndrome. Springer-Verlag: Berlin, 1991:265-277.
19. Olsen J, Colby T V, Elliot C G. Hamman-Rich syndrome revisited. Mayo Clinic Proc 1990; 65: 1538-1548.
20. Pratt D S, Schwarz M I, May J J, Dreisen R B. Rapidly fatal pulmonary fibrosis: The accelerated variant of interstitial pneumonitis. Thorax 1979; 34: 587-593.
21. Guest C K, Sim K M, Morgan C J, Evans T W, Keogh B F. Cryptogenic fibrosing alveolitis: a critical care dilemma. Thorax 1993; 48:464.
22. Hammer S P. Idiopathic Interstitial Fibrosis. In: Dail D H, Hammer S P, eds. Pulmonary Pathology. Springer-Verlag: New York, 1993: 647-678.
23. Johnstone I, Britton J, Kinnear W, Logan R. Rising mortality from cryptogenic fibrosing alveolitis. BMJ 1990; 301: 1017-1021.
24. Scadding J G. Chronic diffuse interstitial fibrosis of the lungs. BMJ 1960; 1:443-450.
25. Stack B H R, Grant I W B, Irvine W J, Moffat M A J. Idiopathic diffuse interstitial lung disease. Am Rev Resp Dis 1965; 92: 939-948.
26. Carrington C B, Gaensler E A, Coutu R E, Fitzgerald M X, Gupta R A. Natural history and treated course of usual and desquamative interstitial pneumonia. N Eng J Med 1979; 298: 801-809.
27. Turner-Warwick M, Burrows B, Johnston A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980; 35:171-180.
28. Hance A J, Crystal R G. Idiopathic pulmonary fibrosis. In: Henley D C, Petty T L, eds. Recent Advances in Respiratory Medicine 2. Churchill Livingstone: Edinburgh, 1983: 249-287.
29. Grant IW B. Cryptogenic fibrosing alveolitis. In: Weatherall D J, Ledingham J G G, Warrell D A, eds. Oxford Textbook of Medicine. Oxford Medical Publications: Oxford, 1989: 15.123-15.125.
30. Marks A. Diffuse interstitial pulmonary fibrosis. Med Clin North Am 1967:51:439-457.
31. Scadding J G. Diffuse pulmonary alveolar fibrosis. Thorax 1974; 29:271-281.
32. Liebow A A, Carrington C B. Alveolar diseases. The interstitial pneumonias. In: Simon M, Potchen E J, Lemay M, eds. Frontiers of Pulmonary Radiology. Grune and Stratton: New York, 1967; 102-141.
33. Rubin E H, Lubliner. The Hamman-Rich Syndrome: review of the literature and analysis of 15 cases. Medicine 1957; 36:397-463.
34. DeRemee R A, Harrison E G, Anderson H A. The concept of classical interstitial pneumonitis-fibrosis (CIP-F) as a clinicopathological syndrome. Chest 1972; 61: 213-220.
35. Crystal R G, Fulmer J D, Roberts W C, Moss M L, Line B R, Reynolds H Y. Idiopathic pulmonary fibrosis, histologie, radiographie, physiologic, scintographic, cytologie and biochemical aspects. Ann Intern Med 1976; 85:769-788.
36. Benson M K, Hughes D T D. Serial pulmonary function testing in Fibrosing alveolitis. Br J Dis Chest 1972; 66: 33-44.
37. Gaensler E A, Carrington C B. Open lung biopsy for chronic diffuse interstitial lung disease: clinical, roentgenographic and physiological correlation in 502 patients. Ann. Thoracic Surg 1980; 30:411-426.
38. Généreux G P. The end stage lung. Radiology 1975; 116:279-2898.
39. Scadding J G, Hinson K F N. Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs). Correlation of histology at biopsy with prognosis. Thorax 1967; 22: 291-304.
40. Grenier P, Chevret S, Biegelman C, Brauner M W, Chastang C, Valeyre D. Chronic diffuse interstitial lung disease: determination of the diagnostic value of clinical data, chest radiography and CT with Bayesian analysis. Radiology 1994; 191: 383-390.
41. Strickland B. High resolution computed tomography in parenchyma! lung disease. Current Imaging 1989; 1: 161-167.
42. Muller N L, Miller R R. Computed tomography of chronic diffuse infiltrating lung disease. Am Rev Resp Dis 1990; 142: 1206-1215 & 1440-1448.
43. Muller N L. Clinical value of high resolution computed tomography in chronic diffuse lung disease. AJR 1991; 157: 1163-1170.
44. Mathieson J R, Mayo J R, Staples C A, Muller N L. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology 1989; 171: 111-116.
45. Tung K T, Wells A U, Rubens M B, Kirk J M E, du Bois R M. Hansell D M. Accuracy of typical tomographic appearances of fibrosing alveolitis. Thorax 1993; 48: 334-338.
46. Reynolds H Y, Fulmer J D, Kazmeirowski J A, Roberts W C, Frank M M, Crystal R G. Analysis of cellular and protein content of bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 1977; 59: 165-175.
47. Turner-Warwick M, Burrows B, Johnson B. Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival. Thorax 1980; 35: 593-599.
48. Augustini C, Xaubet A, Roca J, Agustini A G N, RodriguezRoisin R. Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a 2 year follow up. Thorax 1992; 47: 1035-1040.
49. Turner-Warwick M, Lebowitz M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis and lung cancer. Thorax 1980; 35:496-499.
50. Meir-Sydow J, Rust M, Kronenberger H. Diagnosis and therapy in idiopathic pulmonary fibrosis. Allerg et Immunopathol 1980; 8(suppl.): 101-109.
51. Wesse W C, Levine B W, Kazemi H. Interstitial lung disease resistant to corticosteroid therapy. Report of 3 cases treated with azothiaprine and cyclophosphamide. Chest 1975; 67: 57-60.
52. Winterbaur R H, Hammer S P, Hallman K O et al. Diffuse interstitial pneumonitis. Clinicopathological correlation in 20 patients treated with prednisone/azothiaprine. Am J Med 1978; 65:661-672.
53. Johnstone M A, Kwan S, Snell S J C. Randomised controlled trial comparing prednisilone alone with cyclophosphamide and low dose prednisilone in combination in cryptogenic fibrosing alveolitis. Thorax 1989; 44: 280-288.
54. Hunninghake G W, Keogh B A, Crystal R G. Comparison of cyclophosphamide and corticosteroids on lung inflammatory immune responses in idiopathic pulmonary fibrosis. Clin Res 1980; 28:529A.
55. Moolman J A, Bardin P G, Rossoum D J, Jobert J R. Cyclosporin as a treatment for interstitial lung disease of unknown aetiology. Thorax 1991; 46: 592-595.
56. Meir-Sydow J, Rust M, Kronenberger H, Theil C, Amthor M, Riemann H. Long-term follow-up of lung function parameters in patients with idiopathic pulmonary fibrosis treated with prednisilone and azothiaprine or d-penicillamine. Prax Pnemol 1979; 33: 680-688.
57. Cherniack R M, Crystal R G, Kalica A R. NHLBI Workshop Summary. Current concepts in IFF: a roadmap for the future. Am Rev Resp Dis 1991; 143: 680-683.
58. Haslam P L, Turton C W G, Heard B et al. Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features. Thorax 1980; 35: 9-18.
59. Cherniack R M, Banks D E, Bell D Y, Davis G S, Hughe J M, King T E. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis and selected comparison groups. Am Rev Resp Dis 1990; 141(suppl.): S169-S193.
60. Johnstone I D A, Gomm S A, Kalrs S, Woodcock M, Evans C C, Hind C R K. The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom. Eur Resp J 1993; 6: 891-893.
61. Drent M, Mulder P G H, Wagenaar S Se, Hoogsteden H C, van Velzen-Blad H, van den Bosch J M M. Différences in bronchoalveolar lavage fluid variables in interstitial lung disease evaluated by discriminant analysis. Eur Resp J 1993; 6: 803-810.
62. Smith C M, Moser K M. Management of interstitial lung disease: state of the art. Chest 1989; 95: 676-678.
63. Levin D C, Wicks A B, Ellis J H. Transbronchial lung biopsy via the fibreoptic bronchoscope. Am Rev Resp Dis 1974; 110:4-12.
64. Wall C P, Gaensler E A, Carrington C B, Hayes J A. Comparison of transbronchial and open biopsies in chronic infiltrative lung disease. Am Rev Resp Dis 1981; 123: 280-285.
65. Lamb D. Idiopathic interstitial fibrosis. Lung 1990; 168(suppl): 993-997.
66. Katzenstein A A, Askin F B, eds. Idiopathic Interstitial Pneumonia/Idiopathic Pulmonary Fibrosis. In Surgical Pathology of Non-neoplastic Lung Disease. WB Saunders: Philadelphia, 1990: 58-96.
67. Johnstone ID A, Rudd R M. On behalf of the BTS Research Committee. BTS study of cryptogenic fibrosing alveolitis (CFA): investigation, lung function and treatment at diagnosis. Thorax 1994; 49: 365P.
68. Costabel U. Management of idiopathic pulmonary fibrosis: academic postulate and clinical practice. Eur Resp J 1993; 6: 770-771.
69. Carnochan F M, Walker W S, Cameron E W J. Efficacy of video assisted thoracoscopic lung biopsy. An historical comparison with open lung biopsy. Thorax 1994; 49: 361-363.
70. Liebow M, Steer A, Billingsley J G. Desquamative interstitial pneumonia. Am J Med 1965; 39: 369-404.
71. Myers J, Katzenstein A. Epithelial necrosis and alveolar collapse in the pathogenesis of usual interstitial pneumonitis. Chest 1988; 94: 1309-1311.
72. McDonald J A. Idiopathic pulmonary fibrosis: A paradigm for lung injury and repair. Chest 1991; 99(suppl): 87S-93S.
73. Kawanami O, Ferrans V J, Crystal R G. Structure of alveolar epithelial cells in patients with fibrotic lung disorders. Lab Invest 1982; 46:39-53.
74. Herbert F A, Nahmias B B, Gaensler E A, Mac Mahon H E. Pathophysiology of interstitial pulmonary fibrosis. Report of 19 cases and follow up with corticosteroids. Arch Int Med 1962; 10: 628-648.
75. Myers J L. Pathology of drug induced lung disease. In: Katzenstein A A, Askin F B, eds. Surgical Pathology of NonNeoplastic Lung Disease. WB Saunders: Philadelphia, 1990:97-127.